CHARACTERIZATION OF INHIBITORS OF ALDEHYDE DEHYDROGENASE 2 IDENTIFIED THROUGH A HIGH-THROUGHPUT DOCKING APPROACH

CHARACTERIZATION OF INHIBITORS OF ALDEHYDE DEHYDROGENASE IDENTIFIED THROUGH A HIGH-THROUGHPUT DOCKING APPROACH Yvelina Tsvetanova Ivanova Submitted to the faculty of the University Graduate School in partial fulfillment of the requirements for the degree Master of Science in the Department of Biochemistry and Molecular Biology, Indiana University May 2013 Accepted by the Faculty of Indiana University, in partial fulfillment of the requirements for the degree of Master of Science Thomas D Hurley, Ph.D., Chair Mark G Goebl, Ph.D Master’s Thesis Committee _ Edward F Srour, Ph.D ii Dedication This is dedicated to my husband, and my parents… “When you nothing, you feel overwhelmed and powerless But when you get involved, you feel the sense of hope and accomplishment that comes from knowing you are working to make things better.” - Ralph Waldo Emerson iii Acknowledgments ‘Equipped with his five senses, man explores the universe around him and calls the adventure Science.’’ ~Edwin Powell Hubble, The Nature of Science, 1954 I would like to thank Dr Tom Hurley for his continuous mentorship, understanding, patience and confidence in me Thank you for the opportunity to be part of your group and be able to work on one of your research projects I would also like to thank all the PhD students in Dr Hurley’s lab for the continuous encouragement and help I am very privileged to have brilliant mentors guiding me and ready to let me disrupt their work with questions Finally, I would like to thank all the members of the different labs where I fulfilled my project gratefully to the instrumentation that they shared with me iv Table of Contents List of Tables vi List of Figures vii Abbreviations viii Introduction Materials and Methods 16 Results and Discussion 20 Tables 26 Figures 30 References 40 Curriculum Vitae v List of Tables Table The ALDH Superfamily of Enzymes Table Known inhibitors of Aldehyde Dehydrogenases Table Comparison between parent inhibitors #32, 72 and 78 to different structural analogs vi List of Figures Fig ALDH2 3D structure with bound Alda-1(gray atoms) Fig Aldehyde Oxidation and Esterase Hydrolysis Fig Surface representations of the substrate binding topologies of the three human ALDH isoenzymes Fig Predicted binding mode for Compound I72 bound within the substrate binding channel of ALDH2 Fig Structures of the inhibitors identified as possible hits from the computational screening Fig IC50 curves for Inhibitors I32, I72, I74 and I78 on the dehydrogenase activity of ALDH2 Fig IC50 curves for Inhibitors I32, I72, I74, I76 and I78 on the esterase activity for ALDH2 Fig Competition for the NAD-catalyzed activation of the esterase activity for ALDH2 by I72, I74, I76, and I78 Fig Ultraviolet/Visible spectral scans for compounds I72, I76, and I78 Fig 10 The active site of ALDH2 with bound Alda-1 and daidzin superimposed in the substrate-binding channel vii Abbreviations ALDH2 aldehyde dehydrogenase ALDH aldehyde dehydrogenase hALDH2 human aldehyde dehydrogenase RA retinoic acid DEAB 4-Diethylamino benzaldehyde ACP 1-amino cyclopropanol DBH dopamine -hydroxylase 4HNE 4-hydroxynonenal viii Introduction Aldehyde dehydrogenases (ALDH) are a family of seventeen homologous enzymes that catalyze the oxidation of an assortment of endogenous and exogenous aldehydes (1) ALDHs serve as enzymes intended to protect the cells from the damaging effects of these highly reactive compounds Constituents of the aldehyde dehydrogenase (ALDH) superfamily catalyze the oxidation of cytotoxic aldehydes by using NAD(P)+ as the electron acceptor (2, 3) ALDH family members participate in the metabolism of amino acids, steroids, biogenic amines, lipids and vitamins as well as in ethanol, retinol, dopamine and GABA metabolism (4) Table represents the ALDH gene superfamily The gene nomenclature is based on sequence identity within the superfamily such that enzymes sharing less than 40% sequence identity are classified in separate families and those sharing greater than 60% sequence identity constitute distinct subfamilies (28) For instance, members of the ALDH1 family share less than 30% sequence identity with the ALDH3 family, whereas ALDH1A1, ALDH1A2 and ALDH1A3 share approximately 75% sequence identity The only exception to this nomenclature system is ALDH2, which by sequence identity belongs in the ALDH1 family (approximately 68% to ALDH1A1), but the extensive publication record on ALDH2 and its role in ethanol metabolism, made it simpler to retain its original gene designation Recent work has shown that specific ALDH isoenzymes can contribute to the underlying pathology of different diseases Many ALDH isozymes are important in oxidizing reactive aldehydes resulting from lipid peroxidation, and, thus, help maintain cellular homeostasis Increased expression and activity of ALDH isozymes are found in many human cancers and are often associated with poor prognosis (95, 96) Therefore, the development of inhibitors of the different ALDH enzymes is of interest as means to treat some of these disease states The three most extensively studied isoenzymes are ALDH1A1, ALDH2 and ALDH3A1 Each of the isoenzymes displays individual physical and enzymatic properties, such as quarternary structure and substrate specificity The closest homolog of human ALDH2 is human ALDH1B1 with 72% sequence identity, but with less than 60% sequence identity within the substrate binding site (104) In addition to ALDH1B1, the human ALDH1 family also contains the ALDH1A1, ALDH1A2 and ALDH1A3 subfamilies These ALDH1A isozymes are the primary isoenzymes that synthesize Retinoic Acid (RA) from retinal and it is critical in regulating RA signaling and as a consequence is strongly implicated in embryogenesis and development The ALDH1A1 gene product is a cytosolic homo-tetramer (~55 kDa subunits) that is expressed in brain, cornea, lens, retina, Esterase Assay - Inhibitor # 32 100 % activity 80 60 40 20 0.1 Esterase Assay - Inhibitor # 72 10 conc Esterase Assay - Inhibitr #74 100 100 80 60 % activity % activity 80 60 40 40 20 20 0 0.1 10 100 0.1 10 conc 100 1000 conc Esterase Assay - Inhibitor # 76 Esterase Assay - Inhibitor # 78 100 100 80 60 % activity % activity 80 40 20 60 40 20 0 0.1 10 100 0.1 conc 10 100 conc Fig IC50 curves for Inhibitors I32, I72, I74, I76 and I78 on the esterase activity for ALDH2 Note the relative lack of potency for these compounds 36 Inhibitor # 74 Inhibitor # 72 2.5 2.5 1.5 50uM inhib 20uM counts counts 1.5 50uM inhib 20uM 10uM 10uM 5uM 5uM 0.5 0.5 0 0.1 0.2 0.3 0.4 NAD concentration 0.5 0.6 0.1 Inhibitor # 76 0.5 0.6 Inhibitor # 78 1.4 1.6 1.2 1.4 1.2 0.8 50uM inhib 0.6 20uM 10uM 0.4 5uM 0.2 counts counts 0.2 0.3 0.4 NAD concentration 50uM inhib 0.8 20uM 0.6 10uM 0.4 5uM 0.2 0 0.1 0.2 0.3 0.4 NAD concentration 0.5 0.6 0.1 0.2 0.3 0.4 NAD concentration 0.5 0.6 Fig Competition for the NAD-catalyzed activation of the esterase activity for ALDH2 by I72, I74, I76, and I78 Note that the extent of activation is decreased upon increasing concentrations of inhibitors 74 and 76 37 I76 Spectra I72 Spectra Absorbance Absorbance of Nitrophenol 80000 35000 Absorbance 70000 Absorbance of NADH 30000 60000 25000 Intensity (U) 15000 Absorbance of NADH 10000 40000 30000 Absorbance of Nitrophenol 20000 5000 10000 240 340 440 540 Wavelength (nm) 640 740 240 340 440 540 Wavelength (nm) 640 740 I78 Spectra Absorbance 50000 Absorbance of Nitrophenol 45000 40000 Absorbance of NADH 35000 Intensity (U) Intensity (U) 50000 20000 30000 25000 20000 15000 10000 5000 240 340 440 540 Wavelength (nm) 640 740 Fig Ultraviolet/Visible spectral scans for compounds I72, I76 and I78 38 Fig 10 The active site of ALDH2 with bound Alda-1 (reference, yellow sticks) and daidzin (reference, dark grey sticks) superimposed in the substrate-binding channel The structure displayed was generated using PyMoL and the surface displayed represents the accessible surface of the substrate site Atom-type coloring is used to show the molecular properties of the site; grey represents carbon atoms, red represents oxygen atoms, blue represents nitrogen atoms and yellow represents sulfur atoms The active site residue, Cys 302, forms an adduct with incoming aldehydes during aldehyde oxidation, or with incoming esters during ester hydrolysis 39 References Khanna M., Chen C., Kimble-Hill A., Parajuli B., Perez-Miller S., Baskaran S., Kim J., Dria K., Vasiliou V., Mochly-Rosen D., Hurley T Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases J Biol Chem 286(50) 43486-94, 2011 Vasiliou V., Pappa A Polymorphisms of human aldehyde dehydrogenases Consequences for drug metabolism and disease Pharmacology 61, 192-198, 2000 Sladek, N E Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact J Biochem Mol Toxicol 17, 7-23, 2003 Wenzel P., Hink U., Oelze M., Schuppan S., Schaeuble K., Schildknecht S., Ho K., Weiner H., Bachschmid M., Munzel T., Daiber A Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH2) activity Implications for mitochondrial oxidative stress and nitrate tolerance J Biol Chem 282, 792-799, 2007 Marcato P., Dean C., Pan D., Araslanova R., Gillis M., Joshi M., Helyer L., Pan L., Leidal A., Gujar S., Giacomantonio C., Lee P Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis Stem Cells 29(1), 32-45, 2011 Moreb J., Mohuczy D., Ostmark B., Zucali J RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4hydroperoxycyclophosphamide Cancer Chemother Pharmacol 59, 127-136, 2007 Harada S., Okubo T., Nakamura T., Fujii C., Nomura F., Higuchi S., Tsutsumi M A novel polymorphism (-357 G/A) of the ALDH2 gene: linkage disequilibrium and an association with alcoholism Alcohol Clin Exp Res 23, 958-962, 1999 Cheriyan J., Burton T., Bradley T., Wallace S., Maki-Petaja K., Mackenzie I., McEniery C., Brown J., Wilkinson I The effects of urotensin II and urantide on forearm blood flow and systemic haemodynamics in humans Br J Clin Pharmacol 68, 518-523, 2009 Chen C., Budas G., Churchill E., Disatnik M., Hurley T., Mochly-Rosen D Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart Science 321, 1493-1495, 2008 40 10 Churchill N., Disatnik M., Mochly-Rosen D Time-dependent and ethanolinduced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase J Mol Cell Cardiol 46, 278-284, 2009 11 Budas G., Disatnik, M H., Chen, C H., Mochly-Rosen, D Activation of aldehyde dehydrogenase (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCvarepsilon) knockout mice J Mol Cell Cardiol 48, 757764, 2010 12 Von Eitzen U., Meier-Tackmann D., Agarwal D P., Goedde H W Detoxification of cyclophosphamide by human aldehyde dehydrogenase isozymes Cancer Lett 76, 45-9, 1994 13 Duester G.Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid Eur J Biochem 4315-24, 2000 14 Haselbeck R., Hoffmann I., Duester G Distinct functions for Aldh1 and Raldh2 in the control of ligand production for embryonic retinoid signaling pathways Dev Genet 25(4), 353-64, 1999 15 Kim H., Lapointe J., Kaygusuz G., Ong D., Li C., van de Rijn M., Brooks J., Pollack J The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer Cancer Res 65(18), 8118-24, 2005 16 Hsu L., Chang W., Hiraoka L., Hseih C Molecular cloning, genomic organization, and chromosomal localization of an additional human aldehyde dehydrogenase gene, ALDH6 Genomics 24, 333-41, 1994 17 Steward M., Malek K., Xiao Q., Dipple K., Crabb D The novel aldehyde dehydrogenase gene, ALDH5, encodes an active aldehyde dehydrogenase enzyme Biochem Biophys Res Commun 211(1), 144-51, 1995 18 Farrés J., Wang X., Takahashi K., Cunningham S., Wang T., Weiner H Effects of changing glutamate 487 to lysine in rat and human liver mitochondrial aldehyde dehydrogenase A model to study human class aldehyde dehydrogenase J Biol Chem 269(19), 13854-60, 1994 19 Boesch J., Lee C., Lindahl R Constitutive expression of class aldehyde dehydrogenase in cultured rat corneal epithelium J Biol Chem 271(9), 51507, 1996 20 Piatigorsky J Multifunctional lens crystallins and corneal enzymes More than meets the eye.Laboratory of Molecular and Development Biology, National Eye Intitute, National Institutes of Health Ann N Y Acad Sci 842, 7-15, 1998 21 Gopal-Srivastava R Pax-6 and alphaB-crystallin/small heat shock protein gene regulation in the murine lens J Biol Chem 271(38), 23029-36, 1996 41 22 Pappa A., Brown D., Koutalos Y., DeGregori J., White C., Vasiliou V Human aldehyde dehydrogenase 3A1 inhibits proliferation and promotes survival of human corneal epithelial cells J Biol Chem 280(30), 27998-8006, 2005 23 Manzer R., Pappa A., Estey T., Sladek N., Carpenter J., Vasiliou V Ultraviolet radiation decreases expression and induces aggregation of corneal ALDH3A1 Chem Biol Interact 143, 45-53, 2003 24 Zhang J., et al., Insights into oxazaphosphorine resistance and possible approaches to its circumvention Drug Resist Update 8(5), 271-97, 2005 25 Zhang P Inhibition of aldehyde dehydrogenase activity enhances antimycin-induced rat cardiomyocytes apoptosis through activation of MAPL signaling pathway Biomedicine and Pharmacotherapy 65(8), 590-3, 2011 26 Yao L., et al., Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use dependent inhibitor of dopamine synthesis Nature Medicine 16(9), 1024-1028, 2010 27 Hiltbrand E Synergetic bitherapy in mice with xenografts of human prostate cancer using a methional mimic and an aldehyde dehydrogenase inhibitor: systemic intraperitoneal and targeted intra-tumoral administration Curr Med Chem 16(10), 1184-91, 2009 28 Kappaka V., Thompson D., Chen C., Nicolaou K., Juvonen R., Petersen D., Deitrich R., Hurley T., Vasiliou V Aldehyde Dehydrogenase Inhibitors: A Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity and Clinical Application Pharmacol Rev 64(3), 520-39, 2012 29 Mann C., Weiner H Differences in the roles of conserved glutamic acid residues in the active site of human class and class aldehyde dehydrogenases Protein Sci 8(10), 1922-9, 1999 30 Kitson T Human metabolism of alcohol: Regulation Enzymology and metabolism of ethanol 117-132, 1989 31 Somerville L., The metabolism of fungicides Xenobiotica 16(10-11), 1017-30, 1986 32 Staub R., Quistad G., Casida J Mechanism for benomyl action as a mitochondrial aldehyde dehydrogenase inhibitor in mice Chem Res Toxicol 43-535-43, 1998 33 Sellman R., Klemi P Kidney toxicity of 3-methylxanthine in the rat J Appl Toxicol 4(6), 304-7, 1984 34 Niederreither K., Dolle P Retinoic acid in development: towards an integrated view Nat Rev Genet 9(7), 541-53, 2008 42 35 Kikonyogo A., Abriola D., Dryjanski M., Pietruszko R Mechanism of inhibition of aldehyde dehydrogenase by citral, a retinoid antagonist Eur J Biochem 262(3), 704-12, 1999 36 Boyer C., Petersen D The metabolism of 3,7-dimethyl-2,6-octadienal in rat hepatic mitochondrial and cytosolic fractions Interactions with aldehyde and alcohol dehydrogenases Drug Metabolism Dispos 19(1), 81-6, 1991 37 Kronmiller J Blockade of the initiation of murine odontogenesis in vitro by citral, an inhibitor of endogenous retinoic acid synthesis Arch Oral Biol 64552, 1995 38 Tanaka M., Tamura K., Ide H Citral, an inhibitor of retinoic acid synthesis, modifies chick limb development Dev Biol 239-47, 1996 39 Tottmar O., Lindberg P Effects on rat liver acetaldehyde dehydrogenases in vitro and in vivo by coprine, the disulfiram-like constituent of Coprinus atramentarius Acta Pharmacol Toxicol 476-81, 1977 40 Marchner H., Tottmar O Studies in vitro on the inactivation of mitochondrial rat-liver aldehyde dehydrogenase by the alcohol-sensitizing compounds cyanamide, 1-aminocyclopropanol and disulfiram Biochem Pharmacol 21818, 1983 41 Michelot D Poisoning by Coprinus atramentarius Nat Toxins 73-80,1992 42 Tamai H Comparison of cyanamide and disulfiram in effects on liver function Alcohol Clin Exp Res 24(4), 97-99, 2000 43 Keung W., Vallee B Daidzin and daidzein suppress free-choice ethanol intake by Syrian golden hamsters Proc Natl Acad Sci USA 90(21), 1000810012, 1993 44 McGregor N Pueraria lobata hangover remedies and acetaldehydeassociated neoplasm risk Alcohol 469-78, 2007 45 Lowe E Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase J Med Chem 4482-7, 2008 46 Bell R., Smith H Preliminary report on clinical trials of antabuse Med Assoc 286-8, 1949 47 Barth K., Malcolm R Disulfiram: an old therapeutic with new applications CNS Neurol Disord Drug Targets 9(1) 5-12, 2010 48 Lin L., Lin J Antabuse as an affordable and promising anticancer drug Int J Cancer 129(5), 1285-1286, 2010 49 Buac D Disulfiram, and disulfiram derivatives as novel potential anticancer drugs targeting the ubiquitin-proteasome system in both preclinical and clinical studies Curr Cancer Drug Targets 338-46, 2011 43 50 Rekha G., Sladek N Inhibition of human class aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by the naturally occurring compound gossypol Adv Exp Med Biol 133-46, 1997 51 Badawy A., Morgan C Tryptophan metabolites as potent inhibitors of aldehyde dehydrogenase activity and potential alcoholism-aversion therapeutic agents International Congress Series 1304, 344-351, 2007 52 Chen Y., et al Aldehyde dehydrogenase 1B1 is a potential biomarker for human colon cancer Biochem Biophys Res Commun 173-9, 2011 53 Beretta M Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases J Biol Chem 17873-80, 2008 54 Lindahl R Aldehyde dehydrogenases and their role in carcinogenesis Crit Rev Biochem Mol Biol 27(4-5), 283-335, 1992 55 Marchetti S., Brocker C., Stagos D., Vasiliou V Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily Expert Opin Drug Metab Toxicol 4(6), 697-720, 2008 56 Black W., Vasiliou V The aldehyde dehydrogenase gene superfamily resource center Hum Genomics 4(2), 136-42, 2009 57 Hurley T., Edenberg H., Li, TK Pharmacogenomics: The Search for Individualized Therapeutics WileyVCH 417-442, 2002 58 Chen Z., Zhang J., Stamler J Identification of the enzymatic mechanism of nitroglycerin bioactivation Proc Nat Acad Sci USA 99(12), 8306-8311, 2002 59 Chen Z., Foster M., Zhang J., Mao L., Rockman H., Kawamoto T., Kitagawa K., Nakayama K., Hess D., Stamler J An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation Proc Nat Acad Sci USA 102(34), 12159-12164, 2005 60 Kollau A., Hofer A., Russwurm M., Koesling D., Keung W., Schmidt K., Brunner F., Mayer B Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitroglycerin: evidence for the activation of purified soluble guanylate cyclase through direct formation of nitric oxide Biochem J 385(3), 769-77, 2005 61 Yao L., Fan P., Arolfo M., Jiang Z., Olive M., Zablocki J., Sun H., Chu N., Lee J., Kim H., Leung K., Shryock J., Blackburn B., Diamond I Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis Nat Medicine 16(9), 1024-8, 2010 62 Inagaki K., Mochly-Rosen D DeltaPKC-mediated activation of epsilonPKC in ethanol-induced cardiac protection from ischemia J Mol Cell Cardiol 203-11, 2005 44 63 Grant B., Dawson D., Stinson F., Chou S., Dufour M., Pickering R The 12month prevalence and trends in DSM-IV alcohol abuse and dependence Drug Alcohol Depend 74, 223-234, 2004 64 Mackenzie I., Maki-Petaja K., McEniery C., Bao Y., Wallace S., Cheriyan J., Monteith S., Brown M., Wilkinson I Aldehyde dehydrogenase plays a role in the bioactivation of nitroglycerin in humans Arterioscler Thromb Vasc Biol 25(9), 1891-5, 2005 65 Li Y., Zhang D., Jin W., Shao C., Yan P., Xu C., Nebert, D., Harrison D., Huang W., Jin L Mitochondrial aldehyde dehydrogenase-2 Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin J Clin Invest 116(2), 506-11, 2006 66 Vasiliou V., Nebert D Analysis and update of the human aldehyde dehydrogenase gene family Hum-Genomics 2(2), 138-43, 2005 67 Steinmetz C., Peiguang X., Weiner H., Hurley T Structure of mitochondrial aldehyde dehydrogenase: The genetic component of ethanol aversion Structure 5, 701-11, 1997 68 Moore S., Baker H., Blythe T., Kitson K., Kitson T., Baker E Sheep liver cytosolic aldehyde dehydrogenase: The structure reveals the basis for the retinal specificity of class aldehyde dehydrogenases Structure 6(12),15411551, 1998 69 Yoshida A., Huang I., Ikawa M Molecular abnormality in an inactive aldehyde dehydrogenase variant commonly found in Orientals Proc Nat Acad Sci USA 81, 258-261, 1984 70 Farrés J., Wang X., Takahashi K., Cunningham S., Wang T., Weiner H Effect of changing glutamate to lysine in rat and human liver mitochondrial aldehyde dehydrogenase: a model to study human class aldehyde dehydrogenase J Biol Chem, 269(19), 13854-60, 1994 71 Higuchi S., Muramatsu T., Shigemori K., Saito M., Kono H., Dufour M., Harford T The relationship between low Km aldehyde dehydrogenase phenotype and drinking behavior in Japanese J Stud Alcohol 53(2), 170-5, 1992 72 Higuchi S., Matsushita S., Imazeki H., Kinoshita T., Takagi S., Kono H Aldehyde dehydrogenase genotypes in Japanese alcoholics Lancet 343, 741-2, 1994 73 Chao L., Chung Y., Tang H., Li Y Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients Hepatology 19(2), 360-6, 1994 45 74 Tanaka F., Shiratori T., Yokosuka O., Imazeki F., Tsukada T., Omata M High incidence of ADH2*1/ALDH2*1 genes among Japanese alcohol dependents and patients with alcoholic liver disease Hepatology 23(2), 234-9, 1996 75 Crabb D., Edenberg H., Bosron W., Li T Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity The inactive ALDH2*2 allele is dominant J Clin Invest 83(1), 314-316, 1989 76 Wang X., Sheikh S., Saigal D., Robinson L., Weiner H Heterotetramers of human liver aldehyde dehydrogenase expressed in Escherichia coli J Biol Chem 271(49), 31172-31178, 1996 77 Larson H., Weiner H., Hurley T Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase “asian” variant J Biol Chem 280(34), 30550-6, 2005 78 Larson H., Zhou J., Chen Z., Stamler J., Weiner H Hurley T Structural and functional consequences of coenzyme binding to the inactive asian variant of mitochondrial aldehyde dehydrogenase J Biol Chem 282(17), 12940-50, 2007 79 Towell J., Garthwaite T., Wang R Erythrocyte aldehyde dehydrogenase and disulfiram-like side effects of hypoglycemics and antianginals Alc Clin Exp Res 9(5), 438-42, 1985 80 Sydow K., Daiber A., Oelze M., Chen Z., August M., Wendt M., Ullrich V., Mulsch A., Schulz E., Keaney J., Stamler J., Munzel T Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance J Clin Invest 113(3), 482-9, 2004 81 Difabio J., Ji Y., Vasiliou V., Thatcher G., Bennett B Role of mitochondrial aldehyde dehydrogenase in nitrate tolerance Mol Pharmacol 64(5), 1109-16, 2003 82 Jo S., Kim E., Park M., Han C., Park H., Jang Y., Song B., Jo I A Glu487Lys polymorphism in the gene for mitochondrial aldehyde dehydrogenase is associated with myocardial infarction in elderly Korean men Clin Chim Acta 382(1-2), 43-7, 2007 83 Koh J., Biggins J Ligand-receptor engineering and its application towards the complementation of genetic disease and target identification Top Med Chem 5(4), 413-20, 2005 84 Yam G., Zuber C., Roth J A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder FASEB J 19(1), 12-8, 2005 85 Perez-Miller S., Hurley T Coenzyme isomerization is integral to catalysis in aldehyde dehydrogenase Biochemistry 42(23), 7100-9, 2003 46 86 Xiao Q., Weiner H., Crabb D The mutation in the mitochondrial aldehyde dehydrogenase (ALDH2) gene responsible for alcohol-induced flushing increases turnover of the enzyme tetramers in a dominant fashion J Clin Invest 98(9), 2027-2032, 1996 87 DeMaster E., Redfern B., Nagasawa H Mechanisms of inhibition of aldehyde dehydrogenase by nitroxyl, the active metabolite of the alcohol deterrent agent cyanamide Biochem Pharmacol 55(12), 2007-15, 1998 88 Keung W., Klyosov A., Vallee B Daidzin inhibits mitochondrial aldehyde dehydrogenase and suppresses ethanol intake of Syrian golden hamsters Proc Natl Acad Sci USA 94(5), 1675-9, 1997 89 Gao G., Li D., Keung W Synthesis of daidzin analogues as potential agents for alcohol abuse Bioorg Med Chem 11(18), 4069-81, 2003 90 Feldman R., Weiner H Horse liver aldehyde dehydrogenase II Kinetics and mechanistic implications of the dehydrogenase and esterase activity J Biol Chem 247(1), 267-272, 72 91 Ho K., Allali-Hassani A., Hurley T., Weiner H Differential effects of Mg2+ ions on the individual kinetic steps of human cytosolic and mitochondrial aldehyde dehydrogenases Biochemistry 44(22), 8022-9, 2005 92 Allali-Hassani A., Weiner H Interaction of human aldehyde dehydrogenase with aromatic substrates and ligands Chem Biol Interact 130-132, 125-33, 2001 93 Beretta M., Gruber K., Kollau A., Russwurm M., Koesling D., Goessler W., Keung W., Schmidt K., Mayer B Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases J Biol Chem 283(64), 17873-80, 2008 94 Tanei T Association of breast cancer stem cells identified by aldehyde dehydrogenase expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers Clin Cancer Res 4234-41, 2009 95 Ginester C., Hur M., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C., Liu D., Schott A., Hayes D., Birnbaum D., Wicha M., Dontu G ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1(5), 555-67, 2007 96 Jiang F., Qiu Q., Khanna A., Todd N., Deepak J., Xing L., Wang H., Liu Z., Su Y., Stass S., Katz R Aldehyde dehydrogenase is a tumor stem cellassociated marker in lung cancer Mol Cancer Res 7(3), 330-8, 2009 47 97 Jiang F., Qiu Q., Khanna A., Todd N., Deepak J., Xing L., Wang H., Liu Z., Su Y., Stass S., Katz R Aldehyde dehydrogenase is a tumor stem cellassociated marker in lung cancer Mol Cancer Res 7(3), 330-8, 2009 98 Liu Z., Sun Y., Rose J., Chung Y., Hsiao C., Chang W., Kuo I., Perozich J., Lindahl R., Hempel J., Wang B The first structure of an aldehyde dehydrogenase reveals novel interactions between NAD and the Rossmann fold Nature Struct Biol 4, 317-326, 1997 99 Black W., Vasiliou V The aldehyde dehydrogenase gene superfamily resource center Hum Genomics 4(2), 136-42, 2009 100 Ho K., Mukhopadhyay A., Li Y., Mukhopadhyay S., Weiner H A point mutation produced in a class aldehyde dehydrogenase with increased protective ability against the killing effect of cyclophosphamide Biochem Pharmacol 76(5), 690-696, 2008 101 Strickland K., Krupenko N., Dubard M., Hu C., Tsybovsky Y., Krupenko S Enzymatic properties of ALDH1L2, a mitochondrial 10 formyltetrahydrofolate dehydrogenase Chem Biol Interact 191(1-3), 129-36, 2011 102 Perez-Miller S., Younus H., Vanam R., Chen C., Mochly-Rosen D., Hurley T Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase variant Nat Struct Mol Biol 17(2), 159-64, 2010 103 Sheikh S., Ni L., Hurley T., Weiner H The Potential Roles of the Conserved Amino Acids in Human Liver Mitochondrial Aldehyde Dehydrogenas J Biol Chem 272(30), 18817-22, 1997 104 Stagos D., Chen Y., Brocker C., Donald E., Jackson B., Orlicky D., Thompson D., Vasiliou V Aldehyde Dehydrogenase 1B1: Molecular Cloning and Characterization of a Novel Mitochondrial AcetaldehydeMetabolizing Enzyme Drug Metab Dispos 38(10), 1679-87, 2010 105 Niederreither K., Subbarayan V., Dollé P., Chambon P Embryonic retinoic acid synthesis is essential for early mouse post-implantation development Nat Genet 21(4), 444-8, 1999 106 Allen E., Anderson D., Florang V., Khanna M., Hurley T., Doorn J Relative inhibitory potency of molinate and metabolites with aldehyde dehydrogenase 2: Implications for the mechanism of enzyme inhibition Chem Res Toxicol 23(11), 1843-50, 2010 107 Quistad G., Sparks S., Casida J Aldehyde dehydrogenase of mice inhibited by thiocarbamate herbicides Life Sci 55(20), 1537-44, 1994 108 Parajuli B., Kimble-Hill A., Khanna M., Ivanova I., Meroueh S., Hurley T Discovery of novel regulators of aldehyde dehydrogenase isoenzymes Chem Biol Inter 191(1-3), 153-8, 2011 48 Curriculum Vitae Yvelina Tsvetanova Ivanova Education Master of Science in Biochemistry and Molecular Biology Indiana University, Indianapolis, IN May 2013 Graduate Certificate in Biotechnology Indiana University, Indianapolis, IN December 2009 Bachelor of Science in Biotechnology Purdue University, Indianapolis, IN August 2007 Work Experience Scientist Eli Lilly and Company – Indianapolis, IN – Sep 2007 to Present Laboratory Technician Indiana University School of Medicine – Indianapolis, IN – Sep 2005 to Sep 2007 Lab Experience and Job Responsibilities Research Experience Scientist: Eli Lilly and Company, 2007-Present Research related to immunogenicity and special biomarkers Developed and characterized biomarker assays to support clinical drug development Thesis Research: Biochemistry Department, Indiana University School of Medicine, 2010-2012 (Research advisor: Dr Thomas Hurley) Developed a high-throughput screening assay to identify a number of unique compounds that function as inhibitors of ALDH2 Laboratory Technician: Biochemistry Department, Indiana University School of Medicine, 2005-2007 (Supervisor: Dr William Sullivan) Dr Sullivan’s laboratory studies epigenetics and the regulation of gene expression in protozoan parasites My research was on Toxoplasma gondii and mapping the nuclear localization signal of GCN5 B – HAT I achieved proficiency in experimental design, statistical data analysis, and technical writing skills Technology Statistical analysis tools including GraphPad Prism 4.0 and Microsoft Excel Internet databases Utilization of internet resources Professional Strengths and Responsibilities Experience in the field of proteomics Experience in mentoring team members and working with CRO’s, while ensuring timely delivery of results Ability to handle multiple projects and meet deadlines Good communication skills and strong scientific writing Fluent in French and Bulgarian Activities and Volunteering Translator – Indy Translators – Indianapolis, IN – 2010 to Present Volunteer –The United Ways – Indianapolis, IN – 2011 Professional Training and Seminars AAPS American Association of Pharmaceutical Scientists – attended days Immunogenicity training – Seattle, WA 9th Annual Bioassays and Bioanalytical Method Development – attended days Bioassays method development training – Berkeley, CA Publications Parajuli B., Kimble-Hill A., Khanna M., Ivanova I., Meroueh S., Hurley T Discovery of novel regulators of aldehyde dehydrogenase isoenzymes Chem Biol Inter 191, 153-158, 2011 Sloan S., Siegel R., Ivanova-Cox Y., Watson D., Deeg M., Konrad R A novel high-sensitivity electrochemiluminescence (ECL) sandwich immunoassay for the specific quantitative measurement of plasma glucagon Clin Biochem 4, 8-241, 2012 ... ALDH 8A1 ALDH 6A1 9q21.13 15q 22. 1 15q26.3 9p11.1 12q24 .2 3q21 .2 2q23.3 1q23.1 6p 22. 2 6q23 .2 14q24.3 ALDH 3A1 ALDH 3A2 ALDH3B1 ALDH3B2 ALDH1 8A1 ALDH1 6A1 17p11 .2 17p11 .2 11q13 .2 11q13 .2 10q24.3 19q13.33... database (114, Adapted from Strickland et al., 20 11) Gene Name ALDH 4A1 ALDH 7A1 Chromosome location 1p36.13 5q31 ALDH 1A1 ALDH 1A2 ALDH 1A3 ALDH1B1 ALDH2 ALDH1L1 ALDH1L2 ALDH 9A1 ALDH 5A1 ALDH 8A1 ALDH 6A1 ... substrate-binding channel vii Abbreviations ALDH2 aldehyde dehydrogenase ALDH aldehyde dehydrogenase hALDH2 human aldehyde dehydrogenase RA retinoic acid DEAB 4-Diethylamino benzaldehyde ACP 1-amino